<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945265</url>
  </required_header>
  <id_info>
    <org_study_id>264510</org_study_id>
    <nct_id>NCT04945265</nct_id>
  </id_info>
  <brief_title>Effects of Age and Infertility on Ovarian Granulosa Cell Function</brief_title>
  <official_title>Mechanistic Insight Into Ovarian Granulosa Cell Function Based on Age and Cause of Infertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infertility is a life changing disorder, affecting 1 in 7 couples within the UK. Treatment&#xD;
      options pose a significant cost burden to both the NHS and patient when NHS-funded treatment&#xD;
      options are exhausted. This highlights the need for refinements in clinical management&#xD;
      strategies for this patient group. Although there have been advancements in assisted&#xD;
      reproductive technologies, the success rates of techniques such as in vitro fertilization&#xD;
      (IVF) remain low. Surprisingly, the IVF hormonal regimens used by most assisted conception&#xD;
      units fail to take account of patient age, ovarian reserve or cause of infertility when&#xD;
      deciding on treatment regimen, with a 'one size fits all' approach to treatment. The&#xD;
      investigators propose that age and cause of infertility modify the functions and environment&#xD;
      provided by the cells (granulosa cells) that support egg (oocyte) growth and development and&#xD;
      understanding these changes will allow for a more personalised approach to IVF treatment&#xD;
      regimens. The aim of this study therefore is to recruit female patients undergoing IVF with&#xD;
      different causes of infertility and age, and harvest granulosa cells from remaining material&#xD;
      (follicular aspirates) generated at the time of egg retrieval. Granulosa cells will be&#xD;
      cultured in vitro and cellular functions assessed. The investigators will also recruit female&#xD;
      patients with normal fertility undergoing IVF procedure due to other reasons (i.e. egg&#xD;
      freezing, diagnostics of genetic diseases on embryos).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of hormone production, protein and RNA expression</measure>
    <time_frame>0-14 days</time_frame>
    <description>Assessed via cellular signalling responses to endocrine stimulation, production of steroid hormones, protein analysis and RNA analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of cellular responses with age and cause of infertility.</measure>
    <time_frame>12 months</time_frame>
    <description>Assessed via statistical analysis</description>
  </secondary_outcome>
  <number_of_groups>11</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Infertility, Female</condition>
  <condition>Infertility Unexplained</condition>
  <condition>Infertility of Tubal Origin</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Women aged &lt;30</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Women aged 30-36</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Women aged 37-40</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Women aged &gt;40</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Women undergoing egg freezing/male factor infertility/genetic testing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>unidentified cause of infertility</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>PCOS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>endometriosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>tubal disorders</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ovulatory disorders</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>other causes of infertility e.g., fibroids.</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing routine IVF treatment as part of their clinical treatment plan.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any woman that is:&#xD;
&#xD;
          -  fluent in English,&#xD;
&#xD;
          -  capable of giving consent,&#xD;
&#xD;
          -  reproductive age (between the ages of 18-45),&#xD;
&#xD;
          -  is HIV and Hep A and Hep B negative.&#xD;
&#xD;
          -  undergoing IVF treatment for one of the following reasons:&#xD;
&#xD;
               1. unexplained infertility&#xD;
&#xD;
               2. tubal disease&#xD;
&#xD;
               3. egg freezing&#xD;
&#xD;
               4. polycystic ovarian syndrome&#xD;
&#xD;
               5. ovulatory disorders&#xD;
&#xD;
               6. endometriosis&#xD;
&#xD;
               7. male factor infertility&#xD;
&#xD;
               8. any other cause of infertility such as fibroids.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to consent for themselves,&#xD;
&#xD;
          -  Non-fluent English speakers, unless in clinic translators are available&#xD;
&#xD;
          -  Aged less than 18&#xD;
&#xD;
          -  Is HIV or Hep A or B positive, or has not undergone screening.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ovary</keyword>
  <keyword>granulosa cells</keyword>
  <keyword>infertility</keyword>
  <keyword>ageing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

